Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H4R‐antagonist (JNJ‐39758979) in Japanese adults with moderate atopic dermatitis

Publisher: John Wiley & Sons Inc

E-ISSN: 1346-8138|42|2|129-139

ISSN: 0385-2407

Source: THE JOURNAL OF DERMATOLOGY, Vol.42, Iss.2, 2015-02, pp. : 129-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content